CLINICAL_TRIALS
trial_result
· 2010-03-23
Clinical Trial Update: Candesartan Effect in Second Stage Arterial Hypertension [Phase 4]
Summary
A Phase 4 trial evaluating candesartan for Stage II hypertension has completed. The results were posted on 2010-03-23.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Stage II Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-03-23